Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.

Everything has room for improvement, right? Right. When it comes to cancer care, it is no different. Researchers, drug companies and technology innovators are constantly working to improve efficiency and efficacy, racing to create the best and most far-reaching cancer treatments. Significant resources are being dedicated to a rapidly evolving form of cancer therapy that is designed to be more effective than other existing options. However, new innovations have introduced new challenges, and emerging treatments must adapt to overcome these barriers. 
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam

The field of proton therapy is continuing to see explosive growth. In the past decade alone, technological advances have made proton therapy a more accessible, viable option for hospitals and radiotherapy centers. Moreover, clinical applications for proton therapy have evolved, enabling the treatment of a broad range of diseases. 

July 6, 2020 — Hoya Corp. and Hitachi, Ltd. announced a five year contract regarding Endoscopic Ultrasound Systems [EUS] by which the parties will strengthen technical collaboration, and Hitachi will continue supplying diagnostic ultrasound systems and ultrasound sensor related parts used in EUS.

July 6, 2020 — Advanced Radiation Therapy has completed the first AccuBoost Digital installation at Rhode Island Hospital (RIH). This state-of-the-art platform leverages the superior resolution of digital mammography in the delivery of breast radiation therapy.

July 2, 2020 — Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today announced that it has received U.S.

This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

New QuickPoLL survey results are available on how radiologists feel about current business and the impact of COVID-19, and the work that still remains on the road ahead.

July 1, 2020 — A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for prostate cancer and has recently gained wide acceptance at many institutions. However, there has been concern that different institutions perform imaging of different quality.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now